drugset
drugset / Trial / NCT05276323

Medihoney® Derma Cream Treatment for Mild to Moderate Atopic Dermatitis in Children Study

NCT05276323 ↗

Phase 2 Completed 30 enrolled Soroka University Medical Center
RandomizedSingle-groupOpen-labelTreatment

Summary

A randomized, open-label trial comparing Medihoney Derma Cream to Hydrocortisone 1% cream. Children between the ages of 2-18 years old diagnosed with mild to moderate atopic dermatitis with an IGA (Investigator Global Assessment) score of 2-3, and a BSA (Body Surface Area) score of 1%-10% were included.

Timeline

Start
2020-10-01
Primary completion
2021-02-28
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrocortisone Other / unclassified 1 % Topical
Subject Medihoney Derma Cream Unknown — Topical

Indications

atopic eczema